December 2019 - Page 9 of 21

MondayDec 16, 2019 12:34 pm

MCTC Holdings Inc. (MCTC) Expands Cannabinoid Nanoparticle Research and Development to Microscopic Delivery of CBN and THC-V

MCTC Holdings Inc. is a company dedicated to research and development of innovative infusion technologies in the fast-growing area of cannabinoids sciences The company recently announced that it is expanding on development infusion technologies to include lesser known cannabinoids such as cannabinol (CBN) and THC-V, which have possible applications in product that promote sleep and control appetite MCTC has thus far filed five patents and expects to file at least several additional over the coming months The company’s aim is to make the current generation of hemp extract and cannabinoid technologies obsolete Cannabis infusion technology developer MCTC Holdings Inc. (OTC:…

MondayDec 16, 2019 11:59 am

Trxade Group Inc. (TRXD) Reports Consistent Revenue Growth Trend, Plans to Expand Service Offering

Trxade offers drug producers and distributors a transparent trading platform with significant discounts for pharmacies Platform currently has 11,500 independent pharmacies as registered users, reaching an estimated 12 to 15 million patients The company plans to add other healthcare providers to its platform in a future phase During Q3 2019 the company recorded a significant 173 percent increase in revenues Subsidiary Bonum Health established a partnership with Benzer Pharmacy to launch health hubs in areas where residents don’t typically afford primary or collaborative care Business-to-business pharmacy services supplier Trxade Group Inc. (OTCQB: TRXD) has remained consistently profitable over the last…

MondayDec 16, 2019 11:31 am

Predictive Oncology Inc. (NASDAQ: POAI) Notes Indications of Interest in Medical Division; Regains Nasdaq Price Compliance

Several parties have indicated interest in potential acquisition of POAI’s Skyline Medical division The division has seen recent success with growing sales of its patented, FDA-approved STREAMWAY System POAI also regained compliance with Nasdaq’s minimum bid price requirement Predictive Oncology Inc. (NASDAQ: POAI), a company focused on applying artificial intelligence to personalized medicine and drug discovery, has revealed that several parties have indicated interest in the potential acquisition of Skyline Medical, the division of the company that produces and sells the STREAMWAY System (http://ibn.fm/fjuZr). The patented, FDA-approved STREAMWAY System is the first truly continuous, direct-to-drain fluid disposal system designed specifically for…

MondayDec 16, 2019 11:29 am

QualityStocksNewsBreaks – Petroteq Energy Inc. (TSX.V: PQE) (OTC: PQEFF) Releases Update on Oil Production and Oil Quality Baseline

Petroteq Energy (TSX.V: PQE) (OTC: PQEFF) , a fully integrated oil company focused on the development and implementation of its new proprietary technology for oil extraction with producing assets at Asphalt Ridge near Vernal Utah, today announced that, since last reported, it has increased its daily average oil production and made changes to its facility’s oil quality baseline. Among highlights included in the update, Petroteq Energy reported that, since December 9, 2019, the facility has produced an average 200 barrels of oil in 12-hour process shifts - a total of 6 days of the 7 day period, as well as…

MondayDec 16, 2019 10:58 am

QualityStocksNewsBreaks – Siyata Mobile Inc. (TSX.V: SIM) (OTCQX: SYATF) Receives Purchase Orders Totaling Over $900K for 4G/LTE Push-to-Talk Over Cellular Devices

Siyata Mobile (TSX.V: SIM) (OTCQX: SYATF), a developer and provider of cellular communications solutions for enterprise workers and first responders, today announced its receipt of two purchase orders totaling over $900,000 for its connected vehicle and Push-to-talk over Cellular (“PoC”) solutions. According to the update, the company received one order from a new customer for over $600,000 to equip their connected vehicles with Siyata’s 4G/LTE in-vehicle solutions, as well as an additional $300,000 order from first responder contracts, increasing the customer’s total purchase order to over $3.25M since delivery commenced in 2018. “We continue to win new business and see…

MondayDec 16, 2019 10:29 am

QualityStocksNewsBreaks – MCTC Holdings, Inc. (MCTC) Releases CEO Shareholder Letter, Strategic Direction for 2020

MCTC Holdings (OTC: MCTC) today provided a letter to its shareholders to recap 2019 and provide an overview of the company’s plans moving into 2020. Among the topics covered, the letter discussed the company’s reorganization with a new management team led by Arman Tabatabaei, as well as installation of an experienced board of directors. The letter also covered the company’s current strategic direction to re-position in the cannabinoid sciences arena. “It is our team's strong belief that one of the most underserved submarkets of the hemp and cannabis marketplaces relates to the delivery of hemp extracts and cannabinoids to the…

MondayDec 16, 2019 9:55 am

QualityStocksNewsBreaks – Grapefruit Boulevard Investments Inc. (IGNG) Announces FINRA Filing to Change Corporate Name and Stock Ticker Symbol

Grapefruit Boulevard Investments, a Los Angeles based California corporation and wholly owned subsidiary of Imaging3, Inc. (OTCQB: IGNG), (collectively “Grapefruit”), this morning announced that, as of today, December 16, 2019, it has filed with the Financial Industry Regulatory Authority (“FINRA”) to change the company’s corporate name to Grapefruit USA, Inc., and stock ticker symbol to “GUSA,” “GPRE,” “GPFT” or such other symbol as FINRA and Grapefruit may agree. “Now that Grapefruit’s audit is complete and IGNG’s Super 8K has been filed, we are pleased to take this final step to formalize our transition from a development stage medical device company…

FridayDec 13, 2019 3:32 pm

QualityStocksNewsBreaks – Lexaria Bioscience Corp. (CSE: LXX) (OTCQX: LXRP) Focuses on Pioneering New Technologies

Lexaria Bioscience (CSE: LXX) (OTCQX: LXRP) is a global innovator in drug-delivery platforms focused on its patented DehydraTECH-based, drug-delivery technology and formulation development. A recent article discussing the company reads, “Earlier this year, Lexaria moved into its new head office that includes a Health Canada-licensed research and development laboratory that is being used to conduct world-leading research into drug-delivery methods and improvements. In addition to accelerating research in the company’s DehydraTECH drug-delivery platform, Lexaria is also considering issuing a limited commercial release of DehydraTECH version 2.0, which has been shown to deliver 811% more CBD into animal blood than generic…

FridayDec 13, 2019 2:47 pm

QualityStocksNewsBreaks – HTC Extraction Systems (TSX.V: HTC) Boosts Output Capacity through Kase Farma Inc. Acquisition

HTC Extraction Systems (TSX.V: HTC), a hemp-biomass processing entity, recently increased its capability and institutional knowledge through the acquisition of California-based Kase Farma Inc. An article discussing the company reads, “Kase Farma is active in the cultivation of hemp as well as the formulation and extraction of cannabinoids from hemp; the company is also licensed in the State of California to perform activities in those areas. At present, the company operates out of a 22,000-square-foot manufacturing facility and is currently implementing a scaled-up, high-throughput extraction facility that will utilize identity-preserved-grown (IPGrowTM), hemp-based cannabinoid biomass. IPGrowTM, according to the U.S. Department…

FridayDec 13, 2019 2:41 pm

QualityStocksNewsBreaks – Willow Biosciences Inc. (CSE: WLLW) (OTCQB: CANSF) Holds Potential to Supply Biosynthetically Derived Cannabinoids

Willow Biosciences (CSE: WLLW) (OTCQB: CANSF), an emerging biotechnology company focused on the biosynthetic production of cannabinoids, is well positioned to disrupt the cannabis industry supply chain by utilizing its ability to provide biosynthetically derived cannabinoids. A recent article discussing the company reads, “Willow ultimately intends to biosynthetically produce a variety of cannabinoids using biosynthesis, but its first target molecule will be CBD. The company has a fully integrated leadership team based out of Canada and the United States to handle all stages of the upstream cannabinoid development cycle. Additionally, by having two labs in Canada, where cannabis is federally…

Site Search

Company Search

Month: December 2019